arrow_back Back to App

Increased Access to COVID-19 Tests: Easier Approval for EU Tests

This act aims to improve access to COVID-19 tests in the United States. It allows for faster approval of antigen tests already authorized for at-home use in the European Union, without requiring a prescription. This means citizens can more easily and quickly obtain self-test kits.
Key points
Faster COVID-19 Test Approval: Antigen tests from the EU, approved for at-home use, will be available faster in the US.
Easier Access Without Prescription: Citizens will be able to purchase these tests without needing a prescription.
Increased Test Availability: The number of available tests will increase, making it easier to monitor health during the pandemic.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_3516
Sponsor: Sen. Sasse, Ben [R-NE]
Process start date: 2022-01-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Increase Access to COVID Testing Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_3516.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-01-18.

What are the main provisions?

Key points include:

  • Faster COVID-19 Test Approval: Antigen tests from the EU, approved for at-home use, will be available faster in the US.
  • Easier Access Without Prescription: Citizens will be able to purchase these tests without needing a prescription.
  • Increased Test Availability: The number of available tests will increase, making it easier to monitor health during the pandemic.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Sasse, Ben [R-NE].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health